UK-CAB 49: Accountability in the new NHS England


Friday 24 January 2014

Programme

09.30-09.45 Registration, refreshments and expenses
09.45-10.15 Welcome, introductions, UKCAB updates
Setting the scene: Insiders views from HIV CRG reps
10.15-10.40 NHS England: patients at the heart of the agenda – Neil Churchill, Director of Improving patient experience, NHS England
10.40-10.55 BREAK
10.55-11.20 Health Watch England – a platform for action  – Cllr Patrick Vernon OBE, Committee member
11.20-11.45 Local Government & Health & Well-being Boards  – Alyson Morley, Senior Advisor (Transforming Health)
11.45-12.20 How does it all fit together – Panel session with all above speakers
12.20-12.45 ViiV pre-meeting – Simon Collins
12.45-14.00 Lunch
14.00-15.30 Company meeting: ViiV Healthcare
15.30-15.40 Break
15.40–16.45 Feedback from membersUK-CAB AOB
16.45 Meeting close

Presentations from this meeting:

NHS England: Patients at the heart of the agenda

Neil Churchill, 24/01/2014  [PDF, 1.7Mb]

Healthwatch England – a platform for action

Patrick Vernon OBE, 24/01/2014  [PDF, 314Kb]

Local government and Health and Wellbeing Boards

Alyson Morley, 24/01/13  [PDF, 307Kb]

Background reading

NHS Structure [diagram]

This is a diagram that tries to explain the complexity of the new NHS structure. It lists all of the key institutions but also seeks to sketch out the key decision and accountability flows.  It however does not show where patients fit in. Download PDF here

2013-NHS-Structure

Healthwatch England

Healthwatch is the new independent consumer champion that gathers and represents the public’s views on health and social care services in England. It operates both on a national and local level and ensures that the views of the public and people who use the services are taken into account.

More information here:
http://www.nhs.uk/NHSEngland/thenhs/healthregulators/Pages/healthwatch-england.aspx

England’s HIV services face complex new environment
This is an article from the Lancet,  a very good medical journal.  The article looks at the implications for care after the break up of services such as  HIV prevention an care and sexual health services.  Here is the first paragraph from the article:

On April 1, 2013, a major transition in health care began in England through the Health and Social Care Act. The reform included the abolishment of National Health Service (NHS) primary care trusts (PCTs), which oversaw services at a regional level, with their local commissioning powers transferred to the 220 groups of general practitioners, called clinical commissioning groups (CCGs). Sexual health services and HIV prevention (including HIV testing) was also transferred to the control of England’s 353 local authorities (councils), who now find themselves negotiating directly with NHS and other providers to continue these services.

Full article here:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62718-X/fulltext?rss=yes

Engaging with individual patients
Part of the Smart Guides to Engagement series, this guide helps clinical commissioning groups (CCGs) and service providers to enable and support the engagement of individuals with healthcare services. It describes what works and points to sources of help to achieve success. It should be read with Information for Patient Engagement, which can be accessed with the rest of the Smart Guides athttp://www.networks.nhs.uk/nhs-networks/smart-guides

Download the PDF [200Kb] (16 pages) here.

Local Government Authority (LGA)

The LGA is the national voice of local government. It works with councils to support, promote and improve local government. The LGA is a politically-led, cross-party organisation that works on behalf of councils to ensure local government has a strong, credible voice with national government. It aims to influence and set the political agenda on the issues that matter to councils so they are able to deliver local solutions to national problems. More information is here: http://www.local.gov.uk/about

Financial support
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.

The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.

Edit
Published: February 4, 2014
Last edited: February 4, 2014